NOVEL BORNEOL ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE

摘要

PCT No. PCT/EP96/01404 Sec. 371 Date Mar. 13, 1998 Sec. 102(e) Date Mar. 13, 1998 PCT Filed Mar. 29, 1996 PCT Pub. No. WO96/32376 PCT Pub. Date Oct. 17, 1996The invention concernes borneol esters of general formula (I), in which R1 means T-C(O)-CH(OR6)-(NR7aR7b)-R8, C(O)-CH(OR6a)-CH[NR7(C(O)-CH(OR6b)-CH (NR7aR7b)-R8a)]-R8b; R7a R7b are identical or different and means R7; R7 means hydrogen, A, -C(O)R12, -C(O)OR12, -C(O)SR12, -C(O)NHR9d, -C(O)NR9dR9e, -SO2R12, C1-C10 alkyl; R8a, R8b are identical or different and mean R8; R8 means (i), heteroaryl substituted by X3, C7-C16 aralkyl, alkyl; A is B-[O-(CH2)t-C(O)]0 or 1-, farnesyl-P(O)(OR9d)-O-(CH2)t-C(O)-; B means protein kinase-inhibitors or farnesyl protein transferase-inhibitors such as for example farnesyl (ii); and T is a bond, Zi or a group (iii). The borneol esters can influence tubulin polymerisation and tubulin depolymerisation.